- Home
- JUNS vs IPA Comparison
JUNS vs IPA Comparison
Compare JUNS & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JUNS
- IPA
- Stock Information
- Founded
- JUNS 2015
- IPA 1983
- Country
- JUNS United States
- IPA United States
- Employees
- JUNS N/A
- IPA N/A
- Industry
- JUNS
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- JUNS
- IPA Health Care
- Exchange
- JUNS NYSE
- IPA Nasdaq
- Market Cap
- JUNS 17.6M
- IPA 20.6M
- IPO Year
- JUNS 2024
- IPA 2017
- Fundamental
- Price
- JUNS $0.62
- IPA $0.45
- Analyst Decision
- JUNS
- IPA Strong Buy
- Analyst Count
- JUNS 0
- IPA 2
- Target Price
- JUNS N/A
- IPA $4.00
- AVG Volume (30 Days)
- JUNS 101.5K
- IPA 407.1K
- Earning Date
- JUNS 05-20-2025
- IPA 03-28-2025
- Dividend Yield
- JUNS N/A
- IPA N/A
- EPS Growth
- JUNS N/A
- IPA N/A
- EPS
- JUNS N/A
- IPA N/A
- Revenue
- JUNS N/A
- IPA $16,581,105.00
- Revenue This Year
- JUNS N/A
- IPA $4.67
- Revenue Next Year
- JUNS N/A
- IPA $14.15
- P/E Ratio
- JUNS N/A
- IPA N/A
- Revenue Growth
- JUNS N/A
- IPA 1.34
- 52 Week Low
- JUNS $0.51
- IPA $0.27
- 52 Week High
- JUNS $19.51
- IPA $1.36
- Technical
- Relative Strength Index (RSI)
- JUNS N/A
- IPA 52.32
- Support Level
- JUNS N/A
- IPA $0.45
- Resistance Level
- JUNS N/A
- IPA $0.48
- Average True Range (ATR)
- JUNS 0.00
- IPA 0.03
- MACD
- JUNS 0.00
- IPA 0.00
- Stochastic Oscillator
- JUNS 0.00
- IPA 55.57
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.